º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Manufacturing

Medical supply company has signed an exclusive deal with a US firm

Wales-based Hospital Innovations signed a deal with to supply their new Nuvis product

Hospital Innovations, Llantrisant

A Welsh medical supply company has signed an exclusive deal with a US company.

Talbot Green-based Hospital Innovations, a forerunner in the supply specialist products for use in orthopaedic, surgical and corrective procedures, has signed a deal with the US-based company, Integrated Endoscopy to supply their new Nuvis product.

Hospital Innovations will become the sole provider of the high-definition, low-cost single-use endoscope for the arthroscopic surgery market.

Nuvis is a unique single use battery-operated arthroscope that is designed to provide high definition visualization via a proprietary optical design, while directly addressing key safety and sterility issues associated with traditional, reusable arthroscopes.

Hospital Innovations say the Nuvis device eliminates the need for the traditional light source and the associated heat; and can be used on existing imaging systems in the marketplace. Its brand new every time aspect gives surgeons an arthroscope that they can rely on offering HD image quality consistently.

The specific arthroscope marketplace is worth £150m and so far, Hospital Innovations has received a 100% positive reaction from surgeons.

Sarah Lister-Sims, managing director at Hospital Innovations(Image: HUW JOHN)

Sarah Lister-Sims, managing director at Hospital Innovations, said: “This is an exciting and innovative product that will revolutionise patient care and clinical efficacy. We are pleased to be bringing this ground-breaking technology to the º£½ÇÊÓÆµ.”

Brad Sharp, CEO of Integrated Endoscopy, said: “We’re excited to be sharing our NUVIS technology with surgery thought leaders around the world. The response has been overwhelmingly enthusiastic, and it’s gratifying to be able to provide the international surgical community a technology we believe will be a superior, less expensive and safer new gold-standard in arthroscopic surgery.